Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Cancer Gene Therapy
|
December 1, 1995
Vectors in cancer therapy: how will they deliver?
M Blaese, T Blankenstein, M Brenner, et al.
International Journal of Cancer
|
December 23, 2014
Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts
C Perez, A Jukica, J J Listopad, et al.
Experimental Hematology
|
January 1, 1997
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells
A Aicher, J Westermann, S Cayeux, et al.
European Journal of Immunology
|
December 1, 1990
Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity
T Blankenstein, W Q Li, K Uberla, et al.
Gene Therapy
|
February 15, 2001
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
D J Schendel, B Frankenberger, P Jantzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 2, 1998
Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1
M Petersson, J Charo, F Salazar-Onfray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 1997
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10
F Salazar-Onfray, J Charo, M Petersson, et al.
Human Gene Therapy
|
February 11, 1998
Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes
D Jung, E Jaeger, S Cayeux, et al.
Oncogene
|
September 7, 2010
The immune response to sporadic colorectal cancer in a novel mouse model
M Czéh, C Loddenkemper, S Shalapour, et al.
Bone Marrow Transplantation
|
August 10, 2000
Allogeneic vaccination for renal cell carcinoma: development and monitoring
H Pohla, B Frankenberger, B Stadlbauer, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Cancer Gene Therapy
|
December 1, 1995
Vectors in cancer therapy: how will they deliver?
M Blaese, T Blankenstein, M Brenner, et al.
International Journal of Cancer
|
December 23, 2014
Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts
C Perez, A Jukica, J J Listopad, et al.
Experimental Hematology
|
January 1, 1997
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells
A Aicher, J Westermann, S Cayeux, et al.
European Journal of Immunology
|
December 1, 1990
Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity
T Blankenstein, W Q Li, K Uberla, et al.
Gene Therapy
|
February 15, 2001
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
D J Schendel, B Frankenberger, P Jantzer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 2, 1998
Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1
M Petersson, J Charo, F Salazar-Onfray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 1997
Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10
F Salazar-Onfray, J Charo, M Petersson, et al.
Human Gene Therapy
|
February 11, 1998
Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes
D Jung, E Jaeger, S Cayeux, et al.
Oncogene
|
September 7, 2010
The immune response to sporadic colorectal cancer in a novel mouse model
M Czéh, C Loddenkemper, S Shalapour, et al.
Bone Marrow Transplantation
|
August 10, 2000
Allogeneic vaccination for renal cell carcinoma: development and monitoring
H Pohla, B Frankenberger, B Stadlbauer, et al.
Page
of 10